# UBS upgrades MCX to Buy, sets Rs 3,800 target on valuations

2026-08-13T08:50:12+00:00 | Business & Economy | Indian Opinion Desk

Corroboration: 1 independent outlet

UBS has upgraded Multi Commodity Exchange of India (MCX) to Buy from Neutral and raised its 12-month price target to Rs 3,800 from Rs 3,600. The global brokerage cited attractive valuations after a 15% correction from May's peak, resilient trading volumes, and potential regulatory catalysts including Sebi's proposal for Foreign Portfolio Investment in commodity derivatives. UBS raised FY27-FY29 EPS estimates by 4%-9% and sees upside of over 28% from the previous close of Rs 2,962. MCX shares traded at Rs 2,980 on Thursday, up 0.61%. The stock has risen nearly 35% in 2026, 78% in one year, and over 840% in three years. MCX's Q1 FY27 revenue surged 88% year-on-year to Rs 7 billion, supported by a 47% jump in futures average daily turnover. UBS expects EBITDA margins to expand to 77% by FY28 on operating leverage.

## Coverage

- economictimes.indiatimes.com <https://economictimes.indiatimes.com/markets/stocks/news/ubs-upgrades-mcx-rating-to-buy-with-rs-3800-target-price-can-it-boost-the-stock/articleshow/133203886.cms>

Tags: commodity derivatives, MCX, Sebi FPI, stock rating, target price, UBS
Canonical: https://indianopinion.org/ubs-upgrades-mcx-to-buy-sets-rs-3800-target-on-valuations/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/ubs-upgrades-mcx-to-buy-sets-rs-3800-target-on-valuations/#story-in-brief

Review state: restored archive article, accurate at time of publication, not offered to search indexes.
